Seminars in Oncology
Volume 34, Issue 2 , Pages 145-153, April 2007

The Atypical Urothelial Cancer Patient: Management of Bladder Cancers of Non–Transitional Cell Histology and Cancers of the Ureters and Renal Pelvis

  • Timothy Gilligan
  • ,
  • Robert Dreicer

      Affiliations

    • Corresponding Author InformationAddress correspondence to Robert Dreicer, MD, FACP, Department of Solid Tumor Oncology, 9500 Euclid Ave R35, Cleveland, OH 44195.

Department of Solid Tumor Oncology, Taussig Cancer Center, and the Glickman Urologic Institute, Cleveland Clinic, Cleveland, OH.

Non–transitional cell neoplasms of the bladder and upper tract transitional cell carcinomas (ureter and renal pelvis) represent only a small fraction of urothelial carcinomas. Clinicians faced with the rare case are always confronted with management dilemmas complicated by the scarcity of published experience to guide decisions. The current review brings together the best of the limited published data in an attempt to provide some reasonable context to help in the management of these difficult neoplasms.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(06)00482-9

doi:10.1053/j.seminoncol.2006.12.005

Seminars in Oncology
Volume 34, Issue 2 , Pages 145-153, April 2007